DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer

Not Applicable

Terminated

Conditions: Malignant Brain Tumor
Stage IV Lung Cancer

Interventions: Procedure: Usual care
Other: computer-assisted intervention
Other: Distress Thermometer
Other: Profile of Mood States (POMS-B)
Other: Tension-Anxiety Subscale

First Posted Date: 2014-05-01

Last Posted Date: 2015-02-18

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT02128373

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Not Applicable

Withdrawn

Conditions: Kidney/Urinary Cancer

Interventions: Device: optical coherence tomography

First Posted Date: 2014-04-09

Last Posted Date: 2016-10-20

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT02108587

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Completed

Conditions: Untreated Bone Metastases
Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M)

Interventions: Device: NaF PET/MRI
Device: NaF PET/CT
Device: FDG PET/CT

First Posted Date: 2014-04-04

Last Posted Date: 2020-07-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 29

Registration Number: NCT02103634

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: liver biopsy
Device: free-breathing MRI

First Posted Date: 2014-03-26

Last Posted Date: 2022-06-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 52

Registration Number: NCT02095678

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases

Not Applicable

Completed

Conditions: Cardiac Disease
Fever of Unknown Origin
Osteomyelitis
Dementia
FDG Avid Cancers
Inflammatory Disease
Vasculitis

Interventions: Device: positron emission tomography
Device: computed tomography
Device: magnetic resonance imaging

First Posted Date: 2014-03-11

Last Posted Date: 2019-10-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 72

Registration Number: NCT02084147

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma

Phase 2

Withdrawn

Conditions: Stage III Multiple Myeloma
Stage I Multiple Myeloma
Stage II Multiple Myeloma

Interventions: Drug: bortezomib
Drug: cyclophosphamide
Drug: dexamethasone
Other: laboratory biomarker analysis
Other: quality-of-life assessment

First Posted Date: 2014-03-10

Last Posted Date: 2015-04-24

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT02082405

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

Not Applicable

Completed

Conditions: Malignant Neoplasm

Interventions: Other: Tailored education intervention
Other: Standard fall care

First Posted Date: 2014-03-07

Last Posted Date: 2015-10-28

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 91

Registration Number: NCT02081794

Locations: 🇺🇸
Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Robotic Athermal Nerve-Sparing Radical Prostatectomy

Not Applicable

Withdrawn

Conditions: Stage I Prostate Cancer
Stage IIA Prostate Cancer

Interventions: Procedure: robot-assisted laparoscopic surgery
Other: laboratory biomarker analysis
Other: quality-of-life assessment
Other: questionnaire administration

First Posted Date: 2014-03-05

Last Posted Date: 2016-01-22

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT02079155

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

Phase 1

Completed

Conditions: Stage IV Adult Diffuse Large Cell Lymphoma
Stage III Adult Diffuse Large Cell Lymphoma
Stage I Adult Diffuse Large Cell Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma

Interventions: Drug: Carfilzomib
Biological: Rituximab
Drug: Cyclophosphamide
Drug: Doxorubicin hydrochloride
Drug: Vincristine sulfate
Drug: Prednisone
Drug: Pegfilgrastim
Drug: Acyclovir

First Posted Date: 2014-02-27

Last Posted Date: 2024-05-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 48

Registration Number: NCT02073097

Locations: 🇺🇸
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery

Not Applicable

Terminated

Conditions: Lymphedema
Breast Cancer

Interventions: Other: educational intervention
Other: lymphedema survey

First Posted Date: 2014-02-27

Last Posted Date: 2015-10-23

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 17

Registration Number: NCT02073045

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy